A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Celgene
Celgene
Celgene
Jonsson Comprehensive Cancer Center
University of Maryland, Baltimore
European Organisation for Research and Treatment of Cancer - EORTC
University of Louisville
University of Rochester
City of Hope Medical Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Centre Leon Berard
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center